| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |